Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.00
Bid: 47.00
Ask: 48.00
Change: -1.50 (-3.06%)
Spread: 1.00 (2.13%)
Open: 47.50
High: 47.00
Low: 46.00
Yest. Close: 49.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

Fri, 2nd Oct 2020 11:13

(Alliance News) - Life sciences company OptiBiotix Health PLC on Friday noted that partner Seed Health Inc has received approval from the US Food & Drug Administration for an investigational new drug application for DS-01.

DS-01 is a broad spectrum multi-species, multi-strain probiotic which contains OptiBiotix's lactobacillus plantarum, a probiotic that aids elements of cardiovascular and wellbeing.

The regulatory acceptance enables DS-01 to enter a phase II randomised, triple-blind, and placebo-controlled clinical trial to investigate the role of the gut microbiome in patients with Irritable Bowel syndrome and the impact of DS-01 on intestinal microbial communities.

Chief Executive Stephen O'Hara said: "We are pleased to see that Seed has achieved FDA authorisation for an IND in a product containing OptiBiotix's Lactobacillus plantarum LPLDL. OptiBiotix has whole genomic sequencing, built on a strong scientific and clinical evidence base, obtained FDA generally recognised as safe, and pharmaceutical good manufacturing practices manufacture validation for LPLDL which has created the potential for LPLDL to be commercialised as a pharmaceutical drug product."

OptiBiotix shares were up 3.6% at 57.00 pence each in London on Friday morning.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

21 Apr 21 14:44

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

16 Apr 21 15:17

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

23 Mar 21 15:04

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

23 Mar 21 08:06

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

17 Mar 21 15:50

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

18 Feb 21 11:13

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

2 Feb 21 14:38

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

19 Jan 21 16:30

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

11 Jan 21 17:29

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

5 Jan 21 17:55

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

9 Dec 20 16:08

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

18 Nov 20 14:53

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

18 Nov 20 12:23

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

12 Oct 20 14:34

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

12 Oct 20 14:00

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.